GDF2 and ovarian carcinoma: Importantly, HepG2 cells do express ALK2 [23], [24], and data from our laboratory and others indicate that BMP9 is able to bind ALK2 receptor in non-endothelial cells, such as myoblasts, breast tumor cells and ovarian surface epithelial and ovarian cancer cells [27], [35].